MAPT and Alzheimer disease: Specifically, that study found that proteins involved in cytoskeletal function and gluconeogenesis are less abundant in the CSF of African Americans with AD, suggesting that variations in biomarkers, including tau and amyloid beta (Aβ), might reflect broader, race‐specific differences in the brain proteome.